Come up with a name for your new list and we'll add to it:
NeuroDerm raised a round of funding on October 06, 2010. Investors include
The Michael J. Fox Foundation.
NeuroDerm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhan…